Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiotensin-converting enzyme inhibitors and renal function.

N A Mason1

  • 1College of Pharmacy, University of Michigan, Ann Arbor 48109.

DICP : the Annals of Pharmacotherapy
|May 1, 1990
PubMed
Summary

Angiotensin-converting enzyme (ACE) inhibitors impact kidney function differently based on patient conditions. While beneficial in some hypertension and heart failure cases, they can harm kidney function in renovascular hypertension and decompensated heart failure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.

Clinical nephrology·2003
Same author

Sildenafil inhibits hypoxia-induced pulmonary hypertension.

Circulation·2001
Same author

Methicillin resistance patterns associated with peritonitis in a university-based peritoneal dialysis center.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2001
Same author

Characterization of adenylyl cyclase isoforms in rat peripheral pulmonary arteries.

American journal of physiology. Lung cellular and molecular physiology·2001
Same author

Intravenous iron products.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association·2000
Same author

Intravenous iron products.

ANNA journal·2000

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • The effects of ACE inhibitors on renal hemodynamics are variable.
  • Previous studies show conflicting results in primary essential hypertension.
  • Renovascular hypertension and congestive heart failure (CHF) present unique challenges for ACE inhibitor use.

Purpose of the Study:

  • To review the varied effects of ACE inhibitors on renal hemodynamics.
  • To discuss the controversies and risks associated with ACE inhibitors in specific renal and cardiac conditions.
  • To explore the emerging role of ACE inhibitors in managing proteinuria.

Main Methods:

  • Literature review and synthesis of existing studies on ACE inhibitors and renal function.
  • Analysis of clinical outcomes in patients with hypertension, renal impairment, renovascular disease, CHF, and proteinuria.

Related Experiment Videos

  • Comparison of different ACE inhibitors regarding renal function effects.

    • Main Results:

    • ACE inhibitors can increase GFR in some hypertensive patients with renal impairment but may worsen renal function in renovascular hypertension.
    • In CHF, ACE inhibitors can improve GFR in stable cases but may cause deterioration in decompensated states.
    • Longer-acting ACE inhibitors like enalapril and lisinopril may have higher incidences of renal function deterioration than captopril in CHF.
    • ACE inhibitors show promise in reducing proteinuria, particularly in diabetic and hypertensive patients with glomerular disorders.

    Conclusions:

    • ACE inhibitor efficacy and safety on renal hemodynamics are highly dependent on the patient's underlying condition.
    • Cautious initiation and monitoring are crucial when using ACE inhibitors in CHF and renovascular hypertension.
    • Further research is needed to optimize ACE inhibitor use for proteinuria and slow renal failure progression.